4//SEC Filing
Meline David W 4
Accession 0001127602-22-020829
CIK 0001682852other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:52 PM ET
Size
8.9 KB
Accession
0001127602-22-020829
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Meline David W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-09+348→ 3,021 total - Sale
Common Stock
2022-08-10$173.66/sh−164$28,481→ 2,857 total - Exercise/Conversion
Restricted Stock Units
2022-08-09−348→ 3,482 totalExercise: $0.00→ Common Stock (348 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Includes 90 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 31, 2022.
- [F3]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F4]25% of the shares subject to this restricted stock unit award vested on February 9, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Documents
Issuer
Moderna, Inc.
CIK 0001682852
Entity typeother
Related Parties
1- filerCIK 0001444612
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:52 PM ET
- Size
- 8.9 KB